Balyasny Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $867K | Buy |
|
|||||
|
2024
Q3 | $743K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $9.85M | Buy |
|
|||||
|
2023
Q3 | $8.34M | Sell |
|
|||||
|
2023
Q2 | $37.9M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $455K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.06M | Buy |
|
|||||
|
2021
Q3 | $2.26M | Sell |
|
|||||
|
2021
Q2 | $1.83M | Sell |
|
|||||
|
2021
Q1 | $7.99M | Buy |
|
|||||
|
2020
Q4 | $1.38M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.1M | Buy |
|